Different owners need different evidence views.
FDA CSACSV/CSA lead
This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for FDA CSA.
quality approver
This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for FDA CSA.
system owner
This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for FDA CSA.
process owner
This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for FDA CSA.
IT owner
This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for FDA CSA.
vendor manager
This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for FDA CSA.
automation lead
This actor needs a clear route from source interpretation to owned evidence, decision, and follow-up for FDA CSA.
Where iFeed can help without overclaiming.
bridge workSource-to-evidence mapping
Convert source material into evidence objects, owners, gaps, and next actions.
Checklist evaluation
Review completed readiness sheets and identify unclear or unsupported claims.
Governance sprint
Create a practical two-week route for inventory, role mapping, evidence review, and update protocol.
Training/workshop
Turn source reading into role-specific literacy and operational confidence.
Current public sources for FDA CSA.
official firstThese links are the public source anchors for this workspace. Interpretation, checklists, and future assets should point back here before being reused outside iFeed.
FDA CSA guidance
2026-02 · Current final guidance on computer software assurance for production and quality management system software; it supersedes the September 2025 final guidance.
FDA CSA guidance PDF
2026-02 · Guidance history notes February 2026 revisions to align terminology with QMSR amendments to Part 820.